Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zastaprazan-based triple therapy for H. pylori eradication
NCT07115173Phase 4Not yet recruiting
- Sponsor
- Samsung Medical Center
- Start
- Dec 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of zastaprazan in Helicobacter pylori infection, sponsored by Samsung Medical Center. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
zastaprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07115173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07115173.